Optimizing Access to Monoclonal Antibodies for COVID-19: US Perspective

Drs Razonable and Huang share their insights on providing treatment with monoclonal antibodies with neutralizing activity against SARS-CoV-2.

Credit available for this activity expires: [03/26/2022]

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/948077?src=mkm_podcast_addon_948077